ARCHIVES

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

Report Urges Enhancement Of Cancer Data Systems.

October 20, 2000

In Brief: Weinstein Names Permanent Director Of Columbia Comprehensive Center; Gottsman Heads Institute

February 8, 1985

NCCN Guidelines Retain Avastin For Breast Cancer

October 22, 2010

Cancer Groups Fear Clinical Trials Coverage Will Not Be Implemented Across Exchanges

July 3, 2013

Home Test Detects Hematuria Earlier

August 4, 1989

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013